ZBIO
Financials
- Market Capitalization 2.04 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1975 |  ADMA ADMA Biologics Inc - Common Stock | 9.34 USD | -1.48% | -4.69% | +9.62% | -45.35% | 2.09 B USD | ||
| 1994 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +8.10% | +59.78% | 2.04 B USD | ||
| 2006 |  ZYME Zymeworks Inc. - Common Stock | 28.27 USD | -2.55% | -1.40% | +28.38% | +59.36% | 2.01 B USD | ||
| 2007 |  NBTX Nanobiotix S.A. - ADSs | 41.23 USD | -8.70% | +1.25% | +7.88% | +397.35% | 2.00 B USD |
Frequently asked questions about Zenas BioPharma, Inc. Common Stock
What is the Zenas BioPharma, Inc. Common Stock stock price today?
The current price of Zenas BioPharma, Inc. Common Stock (ZBIO) is 31.27. Over the past 24 hours, the stock has changed by -4.14%. Follow the ZBIO chart for real-time price dynamics.
What is the stock ticker of Zenas BioPharma, Inc. Common Stock?
Zenas BioPharma, Inc. Common Stock trades under the ticker ZBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zenas BioPharma, Inc. Common Stock stock going up?
ZBIO has changed by -3.49% over the last week, -0.32% over the last month, and +18.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Zenas BioPharma, Inc. Common Stock?
Zenas BioPharma, Inc. Common Stock currently has a market capitalization of 2.04 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Zenas BioPharma, Inc. Common Stock release financial reports?
Yes. You can track Zenas BioPharma, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Zenas BioPharma, Inc. Common Stock earnings last quarter?
Last quarter, Zenas BioPharma, Inc. Common Stock reported earnings of -1.77 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Zenas BioPharma, Inc. Common Stock revenue for the last quarter?
Zenas BioPharma, Inc. Common Stock reported quarterly revenue of 1 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Zenas BioPharma, Inc. Common Stock net income for the last quarter?
Zenas BioPharma, Inc. Common Stock reported net income of -111.46 M for the last quarter. The previous quarter showed -80.99 M, which means net income changed by -37.62%.
How many employees does Zenas BioPharma, Inc. Common Stock have?
As of the latest available data, Zenas BioPharma, Inc. Common Stock has 167 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Zenas BioPharma, Inc. Common Stock stock?
You can buy Zenas BioPharma, Inc. Common Stock (ZBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zenas BioPharma, Inc. Common Stock stock?
Investing in Zenas BioPharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZBIO chart and related analysis on metatrader.com as part of your research.